XTLB

Xtl Biopharmaceu

• TipRanks·03/24 23:50

  XTL Biopharmaceuticals trading halted, news pending

• Reuters·03/23 20:01

  XTL Biopharmaceuticals CFO Niv Segal Files Initial Beneficial Ownership Statement

• TipRanks·03/22 15:23

  Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested

• TipRanks·03/20 20:27

  XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026

• Seeking Alpha·03/20 20:19

  XTL Biopharmaceuticals announces 1-for-4 ADS ratio change

• Reuters·03/20 20:12

  X T L BIOPHARMACEUTICALS LTD - XTL BIOPHARMACEUTICALS TO CHANGE ADS RATIO FROM 1:100 TO 1:400 EFFECTIVE MARCH 25, 2026

• Benzinga·03/20 20:10

  XTL Biopharma To Implement 1-For-4 Reverse ADS Split, Effective March 25, 2026

• Reuters·03/20 20:10

  XTL Biopharmaceuticals to implement 1-for-4 reverse ADS split on March 25, 2026

• TipRanks·03/10 20:27

  XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires

• TipRanks·03/10 11:35

  Beyond Air announces termination of NeuroNOS agreement with XTL

• Dow Jones·03/10 11:32

  *Beyond Air: Remain Focused on Advancing Core Nitric Oxide Platform and LungFit Programs >XAIR

• Dow Jones·03/10 11:31

  *Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals

• Dow Jones·03/10 11:31

  *Beyond Air: Will Continue to Evaluate Strategic Alternatives for NeuroNOS >XAIR

• Dow Jones·03/10 11:31

  *Beyond Air: Remain Committed to Maximizing the Value of the NeuroNOS Platform >XAIR

• TipRanks·02/27 22:00

  XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination